Review Mechanisms of PDAC subtype heterogeneity and therapy response

被引：39

作者：

Espinet, Elisa ^{[1
,2
]}

Klein, Lukas ^{[3
]}

Pure, Ellen ^{[4
]}

Singh, Shiv K. ^{[3
,5
]}

机构：

[1] Univ Barcelona UB, Sch Med, Dept Pathol & Expt Therapy, Barcelona, Spain

[2] Inst Invest Biomed Bellvitge IDIBELL, Mol Mech & Expt Therapy Oncol Program Oncobell, Barcelona, Spain

[3] Univ Med Ctr Gottingen, Dept Gastroenterol Gastrointestinal Oncol & Endoc, Gottingen, Germany

[4] Univ Penn, Dept Biomed Sci, Philadelphia, PA USA

[5] Univ Med Ctr GOttingen, Clin Res Unit 5002, KFO5002, Gottingen, Germany

来源：

TRENDS IN CANCER | 2022年 / 8卷 / 12期

关键词：

FIBROBLAST HETEROGENEITY; TUMOR; CELL; IDENTIFICATION; DEFINE; GROWTH; DIFFERENTIATION; ADENOCARCINOMA; ENVIRONMENT; POPULATIONS;

D O I：

10.1016/j.trecan.2022.08.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) is clinically challenging due to late diagnosis and resistance to therapy. Two major PDAC subtypes have been defined based on malignant epithelial cell gene expression profiles; the basal-like/squamous subtype is associated with a worse prognosis and therapeutic resistance as opposed to the classical subtype. Subtype specification is not binary, consistent with plasticity of malignant cell phenotype. PDAC heterogeneity and plasticity reflect partly malignant cell-intrinsic transcriptional and epigenetic regulation. However, the stromal and immune compartments of the tumor micro -environment (TME) also determine disease progression and therapy response. It is evident that integration of intrinsic and extrinsic factors can dictate subtype heterogeneity, and thus, delineating the pathways involved can help to reprogram PDAC towards a classical/druggable subtype.

引用

页码：1060 / 1071

页数：12

共 82 条

[51] CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma [J].

Noll, Elisa M. ;

Eisen, Christian ;

Stenzinger, Albrecht ;

Espinet, Elisa ;

Muckenhuber, Alexander ;

Klein, Corinna ;

Vogel, Vanessa ;

Klaus, Bernd ;

Nadler, Wiebke ;

Roesli, Christoph ;

Lutz, Christian ;

Kulke, Michael ;

Engelhardt, Jan ;

Zickgraf, Franziska M. ;

Espinosa, Octavio ;

Schlesner, Matthias ;

Jiang, Xiaoqi ;

Kopp-Schneider, Annette ;

Neuhaus, Peter ;

Bahra, Marcus ;

Sinn, Bruno V. ;

Eils, Roland ;

Giese, Nathalia A. ;

Hackert, Thilo ;

Strobel, Oliver ;

Werner, Jens ;

Buechler, Markus W. ;

Weichert, Wilko ;

Trumpp, Andreas ;

Sprick, Martin R. .

NATURE MEDICINE, 2016, 22 (03) :278-287

[52] In search of definitions: Cancer-associated fibroblasts and their markers [J].

Nurmik, Martin ;

Ullmann, Pit ;

Rodriguez, Fabien ;

Haan, Serge ;

Letellier, Elisabeth .

INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (04) :895-905

[53] Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma [J].

Nywening, Timothy M. ;

Belt, Brian A. ;

Cullinan, Darren R. ;

Panni, Roheena Z. ;

Han, Booyeon J. ;

Sanford, Dominic E. ;

Jacobs, Ryan C. ;

Ye, Jian ;

Patel, Ankit A. ;

Gillanders, William E. ;

Fields, Ryan C. ;

DeNardo, David G. ;

Hawkins, William G. ;

Goedegebuure, Peter ;

Linehan, David C. .

GUT, 2018, 67 (06) :1112-+

[54] GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer [J].

O'Kane, Grainne M. ;

Grunwald, Barbara T. ;

Jang, Gun-Ho ;

Masoomian, Mehdi ;

Picardo, Sarah ;

Grant, Robert C. ;

Denroche, Robert E. ;

Zhang, Amy ;

Wang, Yifan ;

Lam, Bernard ;

Krzyzanowski, Paul M. ;

Lungu, Illinca M. ;

Bartlett, John M. S. ;

Peralta, Melanie ;

Vyas, Foram ;

Khokha, Rama ;

Biagi, James ;

Chadwick, Dianne ;

Ramotar, Stephanie ;

Hutchinson, Shawn ;

Dodd, Anna ;

Wilson, Julie M. ;

Notta, Faiyaz ;

Zogopoulos, George ;

Gallinger, Steven ;

Knox, Jennifer J. ;

Fischer, Sandra E. .

CLINICAL CANCER RESEARCH, 2020, 26 (18) :4901-4910

[55]

Özdemir BC, 2014, CANCER CELL, V25, P719, DOI [10.1016/j.ccell.2015.11.002, 10.1016/j.ccr.2014.04.005]

[56] Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer [J].

Ohlund, Daniel ;

Handly-Santana, Abram ;

Biffi, Giulia ;

Elyada, Ela ;

Almeida, Ana S. ;

Ponz-Sarvise, Mariano ;

Corbo, Vincenzo ;

Oni, Tobiloba E. ;

Hearn, Stephen A. ;

Lee, Eun Jung ;

Chio, Iok In Christine ;

Hwang, Chang-Il ;

Tiriac, Herve ;

Baker, Lindsey A. ;

Engle, Dannielle D. ;

Feig, Christine ;

Kultti, Anne ;

Egeblad, Mikala ;

Fearon, Douglas T. ;

Crawford, James M. ;

Clevers, Hans ;

Park, Youngkyu ;

Tuveson, David A. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (03) :579-596

[57] Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts [J].

Park, JE ;

Lenter, MC ;

Zimmermann, RN ;

Garin-Chesa, P ;

Old, LJ ;

Rettig, WJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36505-36512

[58] EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6 [J].

Patil, Shilpa ;

Steuber, Benjamin ;

Kopp, Waltraut ;

Kari, Vijayalakshmi ;

Urbach, Laura ;

Wang, Xin ;

Kueffer, Stefan ;

Bohnenberger, Hanibal ;

Spyropoulou, Dimitra ;

Zhang, Zhe ;

Versemann, Lennart ;

Boesherz, Mark Sebastian ;

Brunner, Marius ;

Gaedcke, Jochen ;

Stroebel, Philipp ;

Zhang, Jin-San ;

Neesse, Albrecht ;

Ellenrieder, Volker ;

Singh, Shiv K. ;

Johnsen, Steven A. ;

Hessmann, Elisabeth .

CANCER RESEARCH, 2020, 80 (21) :4620-4632

[59] Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systems [J].

Peschke, Katja ;

Jakubowsky, Hannah ;

Schaefer, Arlett ;

Maurer, Carlo ;

Lange, Sebastian ;

Orben, Felix ;

Bernad, Raquel ;

Harder, Felix N. ;

Eiber, Matthias ;

Oellinger, Rupert ;

Steiger, Katja ;

Schlitter, Melissa ;

Weichert, Wilko ;

Mayr, Ulrich ;

Phillip, Veit ;

Schlag, Christoph ;

Schmid, Roland M. ;

Braren, Rickmer F. ;

Kong, Bo ;

Demir, Ihsan Ekin ;

Friess, Helmut ;

Rad, Roland ;

Saur, Dieter ;

Schneider, Gunter ;

Reichert, Maximilian .

EMBO MOLECULAR MEDICINE, 2022, 14 (04)

[60] FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer A Meta-Analytical Review of Published Studies [J].

Petrelli, Fausto ;

Coinu, Andrea ;

Borgonovo, Karen ;

Cabiddu, Mary ;

Ghilardi, Mara ;

Lonati, Veronica ;

Aitini, Enrico ;

Barni, Sandro .

PANCREAS, 2015, 44 (04) :515-521

← 1 2 3 4 5 6 7 8 9 →